DPYSL5 and aceruloplasminemia: Accordingly, the clinical presentations associated with anti-CV2 antibody include cerebellar ataxia, chorea, peripheral and autonomic neuropathies, myelopathy, optic neuritis, and retinitis [1, 3, 4].